The present invention provides an improved process for the synthesis of nebivolol or its pharmaceutically acceptable salts, more particularly hydrochloride salt of formula (l). The present invention further provides a new Form T1 of nebivolol and its pharmaceutically acceptable salts. The present invention also provides pharmaceutical composition and process for the preparation of a solid oral dosage form of nebivolol hydrochloride of formula (I), without the use of wetting agent, and optionally using binder and /or disintegrant. Torrent Research Center, P.O.Bhat-382 482,Dist.Gandhinagar, Gujarat India TORRENT PHARMACEUTICALS LIMITED 811/MUM/2004 A 811/MUM/2004 INDIA 2009-03-20T08:13:10Z 2007-06-22 2004-07-30 304087 C07D407/12 A61K31/35 A61P9/00 NA SHETH RAKESH, ATTANTI SRINIVASARAO VEERAVENKATA, PATEL HASMUKH MATHURBHAI, GUPTA VINODKUMAR, NADKARNI SUNIL SADANAND 20980 0 1213 NA NA 2007-06-22 0 3ItH8TnR 2009-04-30T18:38:08Z 70630 SHETH RAKESH, ATTANTI SRINIVASARAO VEERAVENKATA, PATEL HASMUKH MATHURBHAI, GUPTA VINODKUMAR, NADKARNI SUNIL SADANAND 190 TORRENT PHARMACEUTICALS 46154 /app_images/a/9/5/a/83R6512.jpg 811/MUM/2004 37646 2008-06-13 219014 TORRENT 1JG10YeG